INTERNATIONAL PATENT: NEUROCRINE BIOSCIENCES, INC. FILES APPLICATION FOR "SOLID ORAL PHARMACEUTICAL FORMULATIONS COMPRISING A MUSCARINIC RECEPTOR AGONIST"

GENEVA, March 11 -- NEUROCRINE BIOSCIENCES, INC. (6027 Edgewood Bend CourtSan Diego, California 92130) filed a patent application (PCT/US2025/043573) for "SOLID ORAL PHARMACEUTICAL FORMULATIONS COMPRISING A MUSCARINIC RECEPTOR AGONIST" on Aug 26, 2025. With publication no. WO/2026/050278, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MOORE, JR., Richard Alexander (c/o Neurocrine Biosciences, Inc.6027 Edgewood Bend CourtSan Diego, California 92130)

Abstract: Provided are pharmaceutical formulations and methods of treati...